# Robert G Perry – FDA 483, Nov 21, 2013

Source: https://www.keypedia.com/records/483/robert-g-perry/8b2cd7fb-caf7-4c06-831d-03820eb0dc26

> FDA 483 for Robert G Perry on November 21, 2013. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Robert G Perry
- Inspection Date: 2013-11-21
- Product Type: drugs
- Office Name: Office of Medical Device and Radiological Health Division II
- Summary: Elite Research Institute in Miami, FL, was inspected regarding its conduct of clinical investigations. The inspection revealed significant deficiencies in the conduct and supervision of studies, including issues with investigational product storage, protocol adherence, and timely reporting of deviations. Additionally, the firm failed to maintain adequate and accurate case histories, with missing and inconsistent documentation.

## Related Documents

- [483 - 2025-09-05](https://www.keypedia.com/records/483/robert-g-perry/fee33efe-e953-4ed6-bae7-d42201755849) — date: September 5, 2025

## Related Officers

- [Dawn McCabe](https://www.keypedia.com/people/dawn-mccabe/48c5fe52-4cd6-4531-91c9-71dbe00b8bf2)

Company: https://www.keypedia.com/companies/robert-g-perry/711b8704-6573-4df9-b1f2-035c6b67d776

Office: https://www.keypedia.com/offices/office-of-medical-device-and-radiological-health-division-ii/ae9bd439-479a-420d-9dd8-9fe1fc0863d6